Savant Capital, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Savant Capital, LLC
- $17.8 Billion
- Q3 2025
A detailed history of Savant Capital, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 4,388 shares of RYTM stock, worth $436,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,388
Previous 4,382
0.14%
Holding current value
$436,211
Previous $276,000
60.51%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
282Shares Held
485MCall Options Held
498KPut Options Held
150K-
Perceptive Advisors LLC New York, NY419MShares$41.7 Billion94.44% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$670 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.68MShares$565 Million9.85% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$557 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$497 Million0.01% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.54B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...